title: Human lymphoid target cells for the cytokine-inducing seleno-organic compounds.
abstract: Several seleno-organic compounds including ebselen are known as antiinflammatory and antioxidant agents. They also have glutathione peroxidase-like activity and are inhibitors of leukotrienes and prostaglandins. We have recently discovered that these drugs are inducers of cytokines, mainly interferon gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha) and mitogenic interleukins in human peripheral blood leukocytes (PBL) but not in the mouse or rat lymphoid cells. We described a production of IFN-gamma and TNF-alpha by various subsets of PBL stimulated with 2-phenyl-1,2-benzisoselenazol-3(2H)-one (ebselen) or bis [2-(N-phenyl-carbamoyl)]phenyl diselenide. IFN-gamma was produced mainly by E-rosette positive lymphocytes. However, the presence of monocytes was required for the optimal production of IFN-gamma. Also soluble mediators released by monocytes enhanced IFN-gamma synthesis. On the other hand, TNF-alpha was produced mainly by the adherent monocytes. Its synthesis was enhanced by the addition of T or B lymphocytes or conditioned medium from the culture of the stimulated lymphocytes. The relative concentrations of the subsets of lymphocytes or monocytes was important for the maximum production of both IFN-gamma and TNF-alpha. High concentration of lymphocytes inhibited the cytokine production.
authors.affiliation: Laboratory of Virology, Polish Academy of Sciences, Wrocław.
authors.forename: M
authors.initials: M
authors.lastname: Cembrzyńska-Nowak
authors.forename: A D
authors.initials: AD
authors.lastname: Inglot
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology; D001393:Azoles / Q000494:pharmacology*; D001549:Benzamides / Q000494:pharmacology*; D016207:Cytokines / Q000096:biosynthesis*; D006801:Humans; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000096:biosynthesis; D054833:Isoindoles; D007962:Leukocytes / Q000187:drug effects* / Q000276:immunology; D016131:Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology; D009000:Monocytes / Q000187:drug effects / Q000276:immunology; D016566:Organoselenium Compounds / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
chemical_list: D000276:Adjuvants, Immunologic; D001393:Azoles; D001549:Benzamides; D016207:Cytokines; D054833:Isoindoles; D016566:Organoselenium Compounds; D014409:Tumor Necrosis Factor-alpha; C067619:bis(2-(N-phenylcarboxamido)phenyl)diselenide; C042986:ebselen; D007371:Interferon-gamma